LSA
MDGL icon

Leonteq Securities AG’s Madrigal Pharmaceuticals MDGL Stock Holding History

Leonteq Securities AG’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Buy
30
+14
+88% +$7.17K ﹤0.01% 977
2026
Q1 		$8.38K Sell
16
-13
-45% -$6.21K ﹤0.01% 1082
2025
Q4 		$16.9K Sell
29
-27
-48% -$13.8K ﹤0.01% 1125
2025
Q3 		$25.7K Buy
+56
New +$20.9K ﹤0.01% 1008
2024
Q2 		– Sell
-40
Closed -$10.7K – 1257
2024
Q1 		$10.7K Buy
+40
New +$9.43K ﹤0.01% 1002
2023
Q2 		– Sell
-307
Closed -$74.4K – 1276
2023
Q1 		$74.4K Sell
307
-160
-34% -$43.6K ﹤0.01% 701
2022
Q4 		$136K Buy
+467
New +$45.7K 0.01% 623

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Leonteq Securities AG's MDGL Position: Q2 2026 in Review

Leonteq Securities AG increased its Madrigal Pharmaceuticals (MDGL) stake by 88% in Q2 2026, buying an estimated $7.17K and bringing the position to 30 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Leonteq Securities AG first reported a position in MDGL in Q4 2022 and has held it in 7 quarters since. The position peaked at $136K in Q4 2022. 411 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Leonteq Securities AG held 30 shares of Madrigal Pharmaceuticals worth $16.1K as of Q2 2026.
  • Leonteq Securities AG bought 14 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $7.17K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #977 holding.
  • Leonteq Securities AG first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 7 quarters since.
  • Leonteq Securities AG's Madrigal Pharmaceuticals position peaked at $136K in Q4 2022.
  • 411 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.